Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Armando Anido
Recent news which mentions Armando Anido
Zynerba Pharmaceuticals R&D Expenses For Q1 Reach $7.1M, Here Are The Details
May 15, 2023
Tickers
ZYNE
Tags
Penny Stocks
Benzinga
Earnings
From
Benzinga
Zynerba Pharmaceuticals R&D Expenses For FY22 Reach $21.1M, What About Net Loss?
March 28, 2023
Tickers
ZYNE
Tags
Markets
Cannabis
Armando Anido
From
Benzinga
What's The Role Of The Endocannabinoid System In Fragile X Syndrome? How Can Cannabidiol Treatment Help? New Paper
January 11, 2023
Tickers
ZYNE
Tags
ZYNE
News
premium
From
Benzinga
Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy
December 23, 2022
Tickers
INNO
Tags
Inno
Jolly Mazumdar
Pharmaceuticals
From
Business Journals
CBD-Based Zygel Helps With Anxiety-Related & Behavioral Symptoms In 22q11.2 Deletion Syndrome, Phase 2 Trial Reveals
December 05, 2022
Tickers
ZYNE
Tags
ZYNE
News
premium
From
Benzinga
Zynerba Pharmaceuticals R&D Expanses For Q2 Reach 5.4M, Here Are The Details
August 10, 2022
Tickers
ZYNE
Tags
Benzinga
Earnings
Penny Stocks
From
Benzinga
Zynerba Pharmaceuticals R&D Expenses Reach $5.1M For Q1 2022, Here Are The Details
May 16, 2022
Tickers
CCORF
ZYNE
Tags
Armando Anido
Benzinga
Ladenburg Thalmann & Co/ Inc/
From
Benzinga
Zynerba Pharmaceuticals Reveals Lower Net Loss For Q4 And Full Year 2021
March 01, 2022
Tickers
ZYNE
Tags
ZYNE
News
Cannabis Earnings
From
Benzinga
Zynerba Pharmaceuticals Completes Enrollment For CBD Transdermal Trial For 22q Deletion Syndrome
February 28, 2022
Tickers
ZYNE
Tags
Penny Stocks
Benzinga
ZYNE
From
Benzinga
Cannabis Movers & Shakers: Cresco, Agricor & Botanacor, C3 Industries, Akanda, CULTA, OWP, Zynerba
February 17, 2022
Tickers
AYRWF
CRLBF
HOG
LAD
Tags
Dennis Olis
Benzinga
CRLBF
From
Benzinga
Zynerba Pharmaceuticals Names New CLO & Corporate Secretary
February 15, 2022
Tags
executives
Armando Anido
Movers & Shakers
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit